drugset / Trial / NCT04474483

Safety and Efficacy of Melatonin in Outpatients Infected With COVID-19

NCT04474483

Phase 2 Terminated 8 enrolled State University of New York at Buffalo
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is a pilot randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of melatonin in adult outpatients suspected to be afflicted with COVID-19.

Timeline

Start
2020-11-06
Primary completion
2022-07-22
Completion
2022-07-22

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 10 mg Oral

Indications